MedTrace Logo

A Study to Evaluate the Efficacy and Safety of Zingo in Chinese Children

NCT03653260 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 288

Last updated 2019-09-24

No results posted yet for this study

Summary

The purpose of the study is to evaluate the efficacy and safety of Zingo in treating pain associated with venipunture and peripheral venous cannulation.

Conditions

  • Catheter Site Pain
  • Pain, Acute
  • Anesthesia, Local

Interventions

DRUG

Lidocaine (Zingo)

0.5 mg lidocaine, 20 bar pressure

DRUG

Placebo

Placebo injector, 20 Bar pressure, empty injector

Sponsors & Collaborators

  • Zhaoke (Hefei) Pharmaceutical Limited

    collaborator UNKNOWN

  • Lee's Pharmaceutical Limited

    lead INDUSTRY

Principal Investigators

  • Mazhong Zhang, MD · Shanghai Children's Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
3 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-08-15
Primary Completion
2019-02-28
Completion
2019-05-21

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03653260 on ClinicalTrials.gov